TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
about
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisTheiler's virus infection: a model for multiple sclerosisAcute disseminated encephalomyelitisAnti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination modelPeptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2TNF biology, pathogenic mechanisms and emerging therapeutic strategiesRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityGlial development: the crossroads of regeneration and repair in the CNSTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingCreation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonistDemyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal modelsThe role of TNFalpha and lymphotoxin in demyelinating disease.MK2 and Fas receptor contribute to the severity of CNS demyelination.Tumor necrosis factor-alpha promotes myocarditis in female mice infected with coxsackievirus B3 through upregulation of CD1d on hematopoietic cells.Divergence of protection induced by bacterial products and sepsis-induced immune suppression.Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac functionBench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation.Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis.Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis.Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?Glial cells as targets for cytotoxic immune mediators.Glial expression of tumor necrosis factor in transgenic animals: how do these models reflect the "normal situation"?The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisTargeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.Tumor necrosis factor-α signaling in macrophages.Identification of new therapeutic targets for prevention of CNS inflammation.Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease.Cytokines in immunotherapy of experimental uveitis.Cytokine-based immunointervention in the treatment of autoimmune diseases.Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitisInhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelinationMolecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis.Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis.Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injuryHeme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation
P2860
Q24293476-9793865D-B511-43B8-859E-DA5E8FFFAB76Q24629115-85B8AB9F-A90C-480C-B7CF-AB7ABC8D30F3Q24680409-B4F88422-7DCF-470C-90CD-6EA7A127F066Q24804031-71A7F9FA-39DB-44DE-B89D-E208C4288899Q24804955-EA9E40E9-D0D6-4477-A1B7-E4F07EE57DBDQ26776492-32490A85-932E-4849-B14A-6D1F127DF6B6Q26800155-549BB6D1-00C5-4D61-84EC-F9F0CEF1A2E5Q26823697-4AB5C6EB-A468-402B-A73C-A0FFEF448D69Q27002391-97AF60C4-3E6F-4843-AD4A-8ECC45C3515FQ27649040-79E222D5-78A0-405F-850B-FE9FBBB23F28Q30251926-EE1CD101-CE23-4B55-8E6B-9201AB6B9A9AQ30483471-1B4ECD5D-09C8-4E25-89AD-F470F2375A5FQ30667754-0F329F44-986B-40F7-8B0E-9F0A6441C9E1Q33333935-2D2C3658-13D8-42FE-81AD-53BB1D01FDB2Q33693892-71A41426-724C-441F-BA24-D45C3807DB41Q33782397-8ACC3846-8EA7-44B9-A833-750C0D1C226CQ33806619-46715EAC-7B5B-407D-99ED-062101FC5399Q33905161-B8C84455-3D3B-412B-B144-29512071B8A1Q33946614-F64B95E4-3BA8-43DC-94BA-A20117993E53Q34005353-7EA3C1CE-DBED-4B6C-A160-20EF8BD3D767Q34013294-30088A91-F8DC-4606-9100-E2885DAE7C8AQ34307160-211941AB-2767-4D13-907C-462B95E67E15Q34355706-F8877C73-E1B8-4A0F-98EB-7247B987474EQ34370120-5AF52853-83B6-4D44-9DE2-2C22E5E70114Q34395739-759B3579-81F9-4380-84AE-7FE3B771AF96Q34398657-42D731D0-E9A3-48FE-94EA-95227C49BE8EQ34398665-C8A3BBFC-42ED-443C-A20A-9CB174E090EFQ34413247-537D6E0F-A099-430F-8A7C-6D7EE7E0185BQ34661922-D0D09E24-E2C7-4B12-B867-F783D2561ED2Q34734335-C4B32934-3DD0-4E29-B49D-7C77955C0E7AQ34837632-EB481517-DBD6-4698-88F7-76F272541D96Q34983446-7A7880CA-1252-4988-8AED-BFF86FDC7CFCQ34993224-6EB904DB-B16A-40DC-9440-A280B7836C83Q35109131-A714A428-12E2-405E-94D4-B425B9AF4B00Q35123080-D49A6F69-7F43-4C33-82F8-AD47155F6916Q35206971-EC9CAA66-7361-42D1-9A65-13EE8625DD5CQ35216972-764C91F4-52E6-4253-804B-F4159944436BQ35540590-61195CEB-C3BD-4ACB-8E7B-6209D24055C3Q35562783-AA812F8B-EB5D-4D2B-B67D-B2989566235AQ35589270-831230D1-4A1D-47CA-8A9F-0C371BED13AF
P2860
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@en
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@nl
type
label
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@en
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@nl
prefLabel
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@en
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@nl
P2093
P921
P356
P1433
P1476
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
@en
P2093
Bernard CC
Bettadapura J
P2888
P356
10.1038/NM0198-078
P407
P577
1998-01-01T00:00:00Z